Heavy marijuana smoking may raise cancer risk, new research warns. Studies from Keck Medicine of USC found that heavy marijuana smokers face elevated risks of both lung cancer types, while daily users may be 3.5 to 5 times more likely to develop head and neck cancers than non-users. Edibles appear to carry no lung cancer risk so far, but the long-term effects of vaping remain unclear.
As marijuana legalization spreads across the U.S., many assume it's a low-risk habit. But new research from Keck Medicine of USC is complicating that picture. Scientists found that heavy marijuana smokers face elevated risks of both small cell and non-small cell lung cancer — the same types linked to tobacco smoking. The culprit? Marijuana smoke shares many of the same carcinogenic chemicals as tobacco, and THC may also trigger DNA-damaging inflammation through the conversion of polycyclic aromatic hydrocarbons (PAHs).
The cancer risk doesn't stop at the lungs. A separate USC study found that daily marijuana users were significantly more likely to develop cancers of the mouth, throat, larynx, and nearby salivary glands. Researchers are also investigating potential links to bladder and gastrointestinal cancers. Importantly, edibles don't appear to raise lung cancer risk, and the jury is still out on vaping — though doctors are already seeing serious inflammatory lung diseases tied to it.
By the Numbers:
Why it matters: With marijuana use rising nationwide, clinicians need to proactively ask patients about frequency and method of use. Heavy, chronic users — especially daily smokers — may warrant closer cancer screening conversations, even as researchers work to define the exact dose-risk threshold.
